Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
RLYB is expected to report earnings to fall 157.42% to -20 cents per share on March 17
Q4'25
Est.
$-0.21
Q3'25
Beat
by $0.56
Q2'25
Beat
by $0.02
Q1'25
Beat
by $0.07
Q4'24
Beat
by $0.55
The last earnings report on November 06 showed earnings per share of 36 cents, beating the estimate of -20 cents. With 396.30K shares outstanding, the current market capitalization sits at 27.71M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RLYB showed earnings on November 06, 2025. You can read more about the earnings report here.